12:00 AM
 | 
Jan 12, 2009
 |  BC Week In Review  |  Company News  |  Deals

Cellectis, genOway deal

Cellectis ended its October 2001 non-exclusive, worldwide license deal with genOway covering the use of homologous recombination for cellular and...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >